In a global world of commercialization and multiple interfaces of regional health care systems a well targeted market access and reimbursement strategy is the key to successfully launching innovative medical products and new treatment methods in a cost sensitive health care environment.

Our mission is to develop and to ensure market access with sufficient funding for new and innovative treatment methods. We are optimizing regional and national reimbursement (long term) alongside with potential interim funding (short term) and accompany the necessary processes up to implementation.